ARID1A GENE MUTATION
Clinical trials for ARID1A GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ARID1A GENE MUTATION trials appear
Sign up with your email to follow new studies for ARID1A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug JAB-2485 tested in advanced cancers – hope for shrinking tumors
Disease control Recruiting nowThis study tests a new drug called JAB-2485 in adults with advanced solid tumors (like breast or lung cancer) that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. About 102 participants will take the dr…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:20 UTC
-
Targeted drug cocktail aims to shrink Hard-to-Treat uterine cancers
Disease control Recruiting nowThis study tests whether combining two drugs—avelumab (an immunotherapy) and M1774 (a targeted pill)—can shrink or slow the growth of recurrent endometrial cancer in people whose tumors have a specific genetic change (ARID1A mutation). About 25 participants will receive the combi…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE2 • Sponsor: Panagiotis Konstantinopoulos, MD, PhD • Aim: Disease control
Last updated May 18, 2026 12:13 UTC